Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-26
2006-09-26
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S561000
Reexamination Certificate
active
07112606
ABSTRACT:
Heterocyclic arylsulfonamidobenzylic compounds are provided which are useful in treating lipid disorders, metabolic disorders and cell-proliferative diseases.
REFERENCES:
patent: 3281466 (1966-10-01), Stecker et al.
patent: 3495177 (1968-10-01), Jones et al.
patent: 4093738 (1978-06-01), Hubele
patent: 4093742 (1978-06-01), Neustadt
patent: 4107303 (1978-08-01), Aldrich et al.
patent: 4166123 (1979-08-01), Harrison et al.
patent: 4187232 (1980-02-01), Evans et al.
patent: 4199597 (1980-04-01), Neustadt et al.
patent: 4204002 (1980-05-01), Hubele
patent: 4218448 (1980-08-01), Aldrich et al.
patent: 4230635 (1980-10-01), Neustadt
patent: 4235928 (1980-11-01), Eicken et al.
patent: 4240979 (1980-12-01), Baumann et al.
patent: 4251534 (1981-02-01), Aldrich et al.
patent: 4251659 (1981-02-01), Aldrich et al.
patent: 4267193 (1981-05-01), Neustadt et al.
patent: 4501746 (1985-02-01), Krumkalns
patent: 5310760 (1994-05-01), Washburn et al.
patent: 5439915 (1995-08-01), Commons et al.
patent: 5861532 (1999-01-01), Brown et al.
patent: 5883106 (1999-03-01), Stevens et al.
patent: 5952368 (1999-09-01), Kertesz et al.
patent: 6030991 (2000-02-01), Chan et al.
patent: 6090853 (2000-07-01), Wetterich et al.
patent: 6156766 (2000-12-01), Arita et al.
patent: 6162830 (2000-12-01), Connor et al.
patent: 6174905 (2001-01-01), Suzuki et al.
patent: 6191170 (2001-02-01), Medina
patent: 6197798 (2001-03-01), Fink et al.
patent: 6201013 (2001-03-01), Bloom et al.
patent: 6211241 (2001-04-01), Islam et al.
patent: 6211242 (2001-04-01), Setoi et al.
patent: 6214880 (2001-04-01), Houze
patent: 6242493 (2001-06-01), Gareau et al.
patent: 6316503 (2001-11-01), Li et al.
patent: 872311 (1979-05-01), None
patent: 25 15 113 (1975-10-01), None
patent: 26 25 227 (1976-12-01), None
patent: 26 25 242 (1976-12-01), None
patent: 44 37 999 (1996-05-01), None
patent: 44 38 020 (1996-05-01), None
patent: 0 012 428 (1980-06-01), None
patent: 0 013 360 (1980-07-01), None
patent: 0 019 745 (1980-12-01), None
patent: 0 023 669 (1981-02-01), None
patent: 0 193 249 (1986-09-01), None
patent: 0 919 542 (1999-06-01), None
patent: 1 507 340 (1978-04-01), None
patent: 6323822 (1988-02-01), None
patent: 0756392 (1995-07-01), None
patent: 07118215 (1995-07-01), None
patent: WO 94/21611 (1994-09-01), None
patent: WO 97/31637 (1997-09-01), None
patent: WO 97/35838 (1997-10-01), None
patent: WO 99/06382 (1999-02-01), None
patent: WO 99/40064 (1999-08-01), None
patent: WO 99/44987 (1999-09-01), None
patent: WO 00/26186 (2000-05-01), None
patent: WO 00/46203 (2000-08-01), None
patent: WO 00/54759 (2000-09-01), None
patent: WO 01/60818 (2001-08-01), None
Grefhorst et al., Am J Physiol Endocrinol Metab. Jun. 7, 2005: [Epub ahead of print], Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice.
Stein et al., Biochimica et Biophysica Acta 1686 (2004), 24-29.
Lund et al., Arterioscler Thromb Vasc Biol., Jul. 2003, 1169-1177.
Chisholm et al., Journal of Lipid Research, vol. 44, 2003, pp. 2039-2048.
Abramovitch, R., et al., “Mechanism of direct side-chain acylamination and aminoarylation of 2- and 4-picoline 1-oxides” J. Chem Soc. 11:561-2, Database CAS Online, Chem Abstr., Accession No. 1981:568016 (1981).
Beckwith, A., et al., “Tandem radical translocation and homolytic aromatic substitution: a convenient and efficient route to oxindoles” J. Chem. Commun. pp. 977-978 (1995).
Chkanikov, N. et al., “Hexafluoroacetone and methyl trifluoropyruvate as precursors of modified esters of n-acyl-n-phenyl-α-amino acids” Bulletin of the Russian Academy of Sciences 41(8) Part 2:1415-1424, 1992.
Database CAS Online on STN, Chem. Abstr., Accession No. 1998:1455, WO 9746524 A1 (F. Hoffman-La Roche A.G., Switz.) Dec. 11, 1997, abstract.
Gilbert et al., “Perhalo ketones-(VI) aromatic amino dervs. of the penhaloacetones” Database 'Online! accession No. 16091f; [Russian Abstract], 1992.
Le Blanc, S., et al., “New access to spiranc β-lactams” Tetrahedron Lett. 33(15):1993-1996 (1992).
Masazumi I. et al., “Photochemical synthesis of spiro-β-lactams” J. Chem. Soc. Chem. Commun. pp. 758-759 (1984).
Masazumi, I., et al., “Photochemistry of 2-(N-acyl-N-alkylamino)cyclohex-2-enones: formation of spiro-β-lactams” Chem. Pharm. Bull. 34(12):4997-5004 (1986).
Miryan et al., “Derivatives of pyridinecarboxylic acids. Synthesis and antiexudative effect of fluorinated derivatives of nicotinamide and isonicotinamide” Database Chemabs 'Online! Chemical Abstract Service, accession No. 86:139798, 11(1):70-2 (1997) [Russian Abstract].
Polishchuck, V. et al., “Electron paramagnetic resonance spectra of 2-arylpolyfluoroisopropyl radicals” Database Chemabs 'Online! Chemical Abstract Service accession No. 91:4737, 3:659-661 (1979) [Russian Abstract].
Schwarz, M., et al., “Solid-phase synthesis of 3,5-disubstituted 2,3-dihydro-1,5-benzothiazepin-r(5H)-ones” J. Org. Chem. 64:2219-2231 (1999).
Laffitte et al., 2002 “Orphan Nuclear Receptors Find a Home in the Arterial Wall,”Current Atherosclerosis Reports,4(3):213-221.
Cao et al., 2003 “Antidiabetic Action of a Liver X Receptor Agonist Mediated by Inhibition of Hepatic Gluconeogenesis,”The Journal of Biological Chemistry,278(2):1131-1136.
Joseph et al., 2003 “Synthetic LXR Ligand Inhibits the Development of Atherosclerosis in Mice,”PNAS.99(11):7604-7609.
Jiao Xian Yun
Kayser Frank
Kopecky David J.
McKendry Sharon
Piper Derek E.
Amgen Inc.
Anderson Rebecca
Jones Day
Saeed Kamal A.
LandOfFree
Heterocyclic arylsulfonamidobenzylic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic arylsulfonamidobenzylic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic arylsulfonamidobenzylic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3545946